Department of Pathology, St. John's Medical College, Bangalore, India.
Cytopathology. 2022 Mar;33(2):230-235. doi: 10.1111/cyt.13082. Epub 2021 Dec 16.
Implementation of quality control measures ensures acceptable performance by a laboratory. This study aims to assess the quality of cervical cytopathology reporting using quality metrics like atypical squamous cells (which include both atypical squamous cells of undetermined significance and atypical squamous cell -cannot rule out high grade squamous intraepithelial lesion)/squamous intraepithelial lesion (ASC/SIL), cytohistological correlation (CHC) and positive predictive value (PPV) of Papanicolaou (Pap) smears for squamous lesions of cervix.
A retrospective study of Pap smears from 2015 to 2020 was performed. The quality metrics analysed include diagnoses of ASCUS, ASC-H and ASCUS/SIL ratio, CHC and PPV. Cases with cervical biopsies/hysterectomy were included for CHC, and discrepancy was defined as discordance in diagnostic category between cytology and histology in the CHC.
A total of 22,695 cervical cytology smears were reported. Unsatisfactory smears (n = 290) were excluded. Squamous lesions were reported in 233 smears, and the Bethesda system of nomenclature was followed. A definitive diagnosis (SILs and SCC) was given in 74% of cases. ASCUS and ASC-H were reported in 47 and 14 cases, respectively. The most common lesion on Pap smear was high-grade squamous intraepithelial lesion (HSIL; n = 92), followed by low-grade squamous intraepithelial lesion (LSIL; n = 64), and two were ungradable SIL. Squamous cell carcinoma (SCC) was reported in 14 smears. The ASC/SIL ratio was 0.38. CHC (n = 139) was 100% for ASC-H, LSIL, SCC and 84.7% for HSIL. A review of discrepant cases suggested sampling and interpretational discrepancy in five and one cases, respectively. The PPV of Pap smear for squamous lesions was 96.4%.
It is essential to have good quality cytopathology reports for early identification, which enables appropriate management. The most commonly used quality indicator for cytopathology is the ASCUS/SIL ratio. This study suggests the inclusion of the CHC and PPV values as quality metrics for Pap smear, since these are easily measurable and serve as a good indicator of quality in cervical cytopathology reporting.
实施质量控制措施可确保实验室的检测结果符合要求。本研究旨在使用质量指标评估宫颈细胞学报告的质量,如非典型鳞状细胞(包括不明确意义的非典型鳞状细胞和非典型鳞状细胞-不能排除高级别鳞状上皮内病变)/鳞状上皮内病变(ASC/SIL)、细胞学与组织学的相关性(CHC)以及巴氏涂片对宫颈鳞状病变的阳性预测值(PPV)。
对 2015 年至 2020 年的巴氏涂片进行回顾性研究。分析的质量指标包括 ASCUS、ASC-H 和 ASCUS/SIL 比值、CHC 和 PPV 的诊断。有宫颈活检/子宫切除术的病例纳入 CHC,CHC 中细胞学和组织学诊断类别不一致定义为有差异。
共报告了 22695 例宫颈细胞学涂片。排除了 290 例不满意的涂片。报告了 233 例鳞状病变,遵循了巴氏命名系统。74%的病例给出了明确诊断(SIL 和 SCC)。分别报告了 ASCUS 和 ASC-H 各 47 例和 14 例。巴氏涂片最常见的病变是高级别鳞状上皮内病变(HSIL;n=92),其次是低级别鳞状上皮内病变(LSIL;n=64),有 2 例为未分级 SIL。报告了 14 例鳞状细胞癌(SCC)。ASC/SIL 比值为 0.38。CHC(n=139)对于 ASC-H、LSIL、SCC 的符合率为 100%,对于 HSIL 的符合率为 84.7%。对有差异的病例进行回顾,发现 5 例和 1 例分别存在取样和解释差异。巴氏涂片对鳞状病变的 PPV 为 96.4%。
良好的细胞学报告对早期识别至关重要,这有助于进行适当的管理。细胞学中最常用的质量指标是 ASCUS/SIL 比值。本研究建议将 CHC 和 PPV 值纳入巴氏涂片的质量指标,因为这些值易于测量,并且是宫颈细胞学报告质量的良好指标。